Showing results (91-100 of 166) with videos related to
Sort By:
Pageof 17
International Journal of Cancer|July 15, 1988
Syngeneic monoclonal antibodies directed against Rauscher virus-induced myeloid leukemic cells: isolation and characterizationD Berends, E H Rhijnsburger, J L van Gaalen, et al.Journal of Clinical Pathology|October 1, 1987
Diagnosis of invasive candidiasis in patients with and without signs of immune deficiency: a comparison of six detection methods in human serumG J Platenkamp, A M Van Duin, J C Porsius, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1989
Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practiceT A Splinter, D N Carney, M Teeling, et al.Cancer Chemotherapy and Pharmacology|January 1, 1992
Phase II study of ACNU as second-line treatment in small-cell lung cancer. EORTC Lung Cancer Cooperative GroupA S Planting, T A Splinter, A Ardizzoni, et al.Clinical Lung Cancer|January 21, 2004
Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) non small-cell lung cancer after a response to induction chemotherapy. EORTC 08941T A Splinter, P E van Schil, G W Kramer, et al.Epidemiology (Cambridge, Mass.)|March 15, 2001
Is there a common etiology for the rising incidence of and decreasing survival with adenocarcinoma of the lung?M L Janssen-Heijnen, J W Coebergh, P J Klinkhamer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinomaV C Tjan-Heijnen, B Biesma, J Festen, et al.Oncogene|November 1, 1989
Activated ras genes in human seminoma: evidence for tumor heterogeneityM P Mulder, W Keijzer, A Verkerk, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic significance of tissue polypeptide-specific antigen (TPS) in patients with advanced non-small cell lung cancerA van der Gaast, C H Schoenmakers, T C Kok, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Rotterdam Oncology Thoracic Study GroupM Salden, T A Splinter, H A Peters, et al.Pageof 17